Income Statement ImmuCell Corporation

Stocks

ICCC

US4525253062

Pharmaceuticals

Market Closed - Nasdaq 01:30:00 24/09/2026 am IST			5-day change	1st Jan Change
9.990 ^USD	0.00%		+3.95%	+62.44%

14/08	ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026
14/08	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

882a4a9bb8b.KjenX36wy5Uc7CniMg2gWNvSGPIC8Man6KmzMPvxgRo.fGPtNAz8uNwrinitY0L2apmTSptaqPPukdnXYta07XFMcvAxD9ik5X2FHQ

Published financial data: IMMUCELL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	1.92Cr	1.86Cr	1.75Cr	2.65Cr	2.76Cr
Total Revenues	1.92Cr	1.86Cr	1.75Cr	2.65Cr	2.76Cr
Cost of Goods Sold, Total	1.06Cr	1.09Cr	1.31Cr	1.81Cr	1.62Cr
Gross Profit	86.56L	76.49L	43.96L	83.48L	1.14Cr
Selling General & Admin Expenses, Total	42.3L	54.54L	52.23L	56.83L	59.54L
R&D Expenses	41.69L	44.94L	43.95L	38.99L	30.42L
Other Operating Expenses, Total	83.99L	99.48L	96.17L	95.81L	89.96L
Operating Income	3L	-22.99L	-52.21L	-12.33L	24.49L
Interest Expense, Total	-3L	-3L	-5L	-6L	-5L
Interest And Investment Income	18.81T	2L	96.57T	77.7T	2L
Net Interest Expenses	-3L	-2L	-4L	-5L	-3L
Other Non Operating Income (Expenses)	-	912	107	-	3.78T
EBT, Excl. Unusual Items	-38.16T	-24.93L	-56L	-17.24L	21.18L
Restructuring Charges	-	-	-	-	-8L
Gain (Loss) On Sale Of Assets	-30.96T	7.33T	-8.1T	-15.39T	-1L
Asset Writedown	-	-	-	-	-26.67L
Insurance Settlements	-	-	4L	-	4L
Other Unusual Items	-	-	-5L	-4L	-
EBT, Incl. Unusual Items	-69.13T	-24.86L	-57.7L	-21.47L	-10.28L
Income Tax Expense	9.16T	7.67T	4.63T	10.06T	11.57T
Earnings From Continuing Operations	-78.29T	-24.94L	-57.75L	-21.57L	-10.4L
Net Income to Company	-78.29T	-24.94L	-57.75L	-21.57L	-10.4L
Net Income - (IS)	-78.29T	-24.94L	-57.75L	-21.57L	-10.4L
Net Income to Common Incl Extra Items	-78.29T	-24.94L	-57.75L	-21.57L	-10.4L
Net Income to Common Excl. Extra Items	-78.29T	-24.94L	-57.75L	-21.57L	-10.4L
Per Share Items
Net EPS - Basic	-0.01	-0.32	-0.75	-0.26	-0.12
Basic EPS - Continuing Operations	-0.01	-0.32	-0.75	-0.26	-0.12
Basic Weighted Average Shares Outstanding	75.92L	77.45L	77.48L	81.67L	90.26L
Net EPS - Diluted	-0.01	-0.32	-0.75	-0.26	-0.12
Diluted EPS - Continuing Operations	-0.01	-0.32	-0.75	-0.26	-0.12
Diluted Weighted Average Shares Outstanding	75.92L	77.45L	77.48L	81.67L	90.26L
Normalized Basic EPS	-0	-0.2	-0.45	-0.13	0.15
Normalized Diluted EPS	-0	-0.2	-0.45	-0.13	0.15
Supplemental Items
EBITDA	27.19L	2L	-25.04L	14.54L	51.79L
EBITA	3L	-22.8L	-52.02L	-12.14L	24.68L
EBIT	3L	-22.99L	-52.21L	-12.33L	24.49L
EBITDAR	28.78L	4L	-21.18L	19.48L	56.58L
Effective Tax Rate - (Ratio)	-13.26	-0.31	-0.08	-0.47	-1.12
Current Domestic Taxes	9.16T	7.67T	4.63T	10.06T	11.57T
Total Current Taxes	9.16T	7.67T	4.63T	10.06T	11.57T
Deferred Domestic Taxes	0	0	0	0	0
Total Deferred Taxes	0	0	0	0	0
Normalized Net Income	-23.85T	-15.58L	-35L	-10.78L	13.24L
Interest on Long-Term Debt	3L	3L	5L	6L	5L
Supplemental Operating Expense Items
Advertising Expense	37.82T	-	-	-	-
Selling and Marketing Expenses	25.04L	31.9L	30.88L	34.66L	35.53L
General and Administrative Expenses	17.26L	22.64L	21.34L	22.17L	24.01L
Research And Development Expense From Footnotes	41.69L	44.94L	43.95L	38.99L	30.42L
Net Rental Expense, Total	2L	2L	4L	5L	5L
Imputed Operating Lease Interest Expense	38.16T	45.48T	1L	1L	1L
Imputed Operating Lease Depreciation	1L	1L	3L	4L	3L
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	1L	3L	4L	3L	3L
Total Stock-Based Compensation	1L	3L	4L	3L	3L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	1.02Cr	57.92L	10L	37.58L	38.07L
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	1.02Cr	57.92L	10L	37.58L	38.07L
Accounts Receivable, Total	26.94L	17.59L	21.85L	37.71L	34.19L
Other Receivables	26.48T	42.18T	39.73T	40.56T	31.18T
Total Receivables	27.21L	18.01L	22.25L	38.12L	34.5L
Inventory	30.9L	60.39L	78.12L	71.13L	92.67L
Prepaid Expenses	3L	4L	5L	4L	4L
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	1.63Cr	1.4Cr	1.15Cr	1.5Cr	1.69Cr
Gross Property Plant And Equipment	4.2Cr	4.65Cr	5.06Cr	5.1Cr	4.43Cr
Accumulated Depreciation	-1.4Cr	-1.59Cr	-1.85Cr	-2.1Cr	-1.88Cr
Net Property Plant And Equipment	2.8Cr	3.06Cr	3.21Cr	2.99Cr	2.55Cr
Long-term Investments	-	-	-	-	-
Goodwill	95.56T	95.56T	95.56T	95.56T	95.56T
Other Intangibles, Total	76.42T	57.31T	38.21T	19.1T	0
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	26.12T	76.63T	57.66T	33.37T	37.69T
Total Assets	4.45Cr	4.49Cr	4.38Cr	4.51Cr	4.25Cr
Liabilities
Accounts Payable, Total	7L	7L	9L	9L	8L
Accrued Expenses, Total	9L	12.06L	12.34L	15.33L	14.8L
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	8L	10.39L	14.29L	14.98L	16.1L
Current Portion of Leases	1L	31.76T	6L	4L	85.49T
Current Income Taxes Payable	2.14T	4.89T	3.05T	5.82T	6.69T
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	18.26T	63.26T	13.18T	8.75T	4.07T
Total Current Liabilities	25.34L	30.72L	41.97L	44.12L	39.78L
Long-Term Debt	83.27L	91.91L	1.05Cr	90.41L	74.89L
Long-Term Leases	10.27L	22.17L	40.77L	41.29L	40.1L
Total Liabilities	1.19Cr	1.45Cr	1.88Cr	1.76Cr	1.55Cr
Common Stock, Total	8L	8L	8L	9L	9L
Additional Paid In Capital	3.57Cr	3.6Cr	3.64Cr	4.09Cr	4.15Cr
Retained Earnings	-37.39L	-62.32L	-1.2Cr	-1.42Cr	-1.52Cr
Treasury Stock	-2L	-1L	-1L	-1L	-1L
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	3.26Cr	3.04Cr	2.5Cr	2.75Cr	2.71Cr
Total Equity	3.26Cr	3.04Cr	2.5Cr	2.75Cr	2.71Cr
Total Liabilities And Equity	4.45Cr	4.49Cr	4.38Cr	4.51Cr	4.25Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	77.43L	77.47L	77.51L	89.83L	90.47L
ECS Total Common Shares Outstanding	77.42L	77.47L	77.51L	89.79L	90.46L
Book Value / Share	4.21	3.92	3.22	3.06	2.99
Tangible Book Value	3.24Cr	3.02Cr	2.49Cr	2.74Cr	2.7Cr
Tangible Book Value Per Share	4.19	3.9	3.21	3.05	2.98
Total Debt	1.03Cr	1.25Cr	1.67Cr	1.51Cr	1.32Cr
Net Debt	89.03T	66.88L	1.57Cr	1.13Cr	93.88L
Debt Equivalent Oper. Leases	12.75L	14.85L	30.86L	39.52L	38.3L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	10L	24.2L	15.94L	13.56L	16.51L
Inventories - Work In Process, Total	19.02L	34.69L	58.15L	57.47L	57.49L
Inventories - Finished Goods, Total	2L	1L	4L	9.53T	18.68L
Land - (BS)	5L	5L	5L	5L	5L
Buildings, Total	1.91Cr	2.01Cr	2.08Cr	2.09Cr	2.09Cr
Machinery, Total	1.83Cr	2.01Cr	2.2Cr	2.23Cr	1.8Cr
Full Time Employees	60	67	74	69	73
Part Time Employees	7	7	5	6	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-
Order Backlog	24L	25L	94L	44L	94L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-78.29T	-24.94L	-57.75L	-21.57L	-10.4L
Depreciation & Amortization - CF	24.42L	24.68L	26.98L	26.68L	27.1L
Amortization of Goodwill and Intangible Assets - (CF)	19.1T	19.1T	19.1T	19.1T	19.1T
Depreciation & Amortization, Total	24.61L	24.88L	27.17L	26.87L	27.3L
Amortization of Deferred Charges, Total - (CF)	7.84T	7.66T	22.62T	42.67T	54.35T
(Gain) Loss From Sale Of Asset	30.96T	-7.33T	8.1T	15.39T	1L
Asset Writedown & Restructuring Costs	-	-	-	-	26.67L
Stock-Based Compensation (CF)	1L	3L	4L	3L	3L
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	10.72T	28.48T	95.72T	-1L	-3L
Change In Accounts Receivable	-9L	9L	-4L	-15.86L	4L
Change In Inventories	-10L	-29.49L	-17.73L	7L	-21.55L
Change In Accounts Payable	2L	3L	2L	4L	-2L
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	26.62T	-2L	-68.86T	1L	-55.23T
Cash from Operations	10L	-15.44L	-46.74L	4L	24.75L
Capital Expenditure	-26.09L	-39.75L	-18.93L	-5L	-12.5L
Sale of Property, Plant, and Equipment	15.29T	11T	2.47T	4.5T	36.13T
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	10L	-	-	-	-
Cash from Investing	-15.97L	-39.64L	-18.9L	-5L	-12.14L
Short Term Debt Issued, Total	-	-	20L	-	-
Long-Term Debt Issued, Total	4L	20L	30L	-	8L
Total Debt Issued	4L	20L	50L	-	8L
Short Term Debt Repaid, Total	-	-	-20L	-	-
Long-Term Debt Repaid, Total	-8L	-9L	-11.86L	-14.68L	-22.8L
Total Debt Repaid	-8L	-9L	-31.86L	-14.68L	-22.8L
Issuance of Common Stock	42.45L	30.67T	18.76T	46.48L	3L
Other Financing Activities, Total	2.27T	-19.31T	-81.53T	-3L	-82.51T
Cash from Financing	38.79L	11.14L	17.51L	28.83L	-12.12L
Net Change in Cash	32.36L	-43.94L	-48.13L	27.79L	48.6T
Supplemental Items
Cash Interest Paid	3L	3L	4L	5L	4L
Cash Income Tax Paid (Refund)	5.11T	4.92T	6.47T	7.29T	10.69T
Levered Free Cash Flow	-16.36L	-46.06L	-45.09L	10.28L	10L
Unlevered Free Cash Flow	-14.47L	-43.95L	-42.34L	13.41L	12.52L
Change In Net Working Capital	16.05L	17.37L	21.64L	4L	20.53L
Net Debt Issued / Repaid	-4L	11.03L	18.14L	-14.68L	-14.79L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	0.38	-3.22	-7.36	-1.73	3.49
Return on Total Capital	0.39	-3.35	-7.72	-1.83	3.69
Return On Equity %	-0.26	-7.92	-20.86	-8.21	-3.81
Return on Common Equity	-0.26	-7.92	-20.86	-8.21	-3.81
Margin Analysis
Gross Profit Margin %	44.98	41.19	25.16	31.51	41.4
SG&A Margin	21.98	29.37	29.89	21.45	21.54
EBITDA Margin %	14.13	1.02	-14.33	5.49	18.73
EBITA Margin %	1.44	-12.28	-29.77	-4.58	8.93
EBIT Margin %	1.34	-12.38	-29.88	-4.65	8.86
Income From Continuing Operations Margin %	-0.41	-13.43	-33.05	-8.14	-3.76
Net Income Margin %	-0.41	-13.43	-33.05	-8.14	-3.76
Net Avail. For Common Margin %	-0.41	-13.43	-33.05	-8.14	-3.76
Normalized Net Income Margin	-0.12	-8.39	-20.03	-4.07	4.79
Levered Free Cash Flow Margin	-8.5	-24.8	-25.81	3.88	3.61
Unlevered Free Cash Flow Margin	-7.52	-23.67	-24.24	5.06	4.53
Asset Turnover
Asset Turnover	0.45	0.42	0.39	0.6	0.63
Fixed Assets Turnover	0.69	0.63	0.56	0.85	1
Receivables Turnover (Average Receivables)	8.57	8.34	8.86	8.9	7.69
Inventory Turnover (Average Inventory)	4.09	2.39	1.89	2.43	1.98
Short Term Liquidity
Current Ratio	6.42	4.56	2.73	3.41	4.26
Quick Ratio	5.09	2.47	0.76	1.72	1.82
Operating Cash Flow to Current Liabilities	0.38	-0.5	-1.11	0.08	0.62
Days Sales Outstanding (Average Receivables)	42.59	43.77	41.2	41.14	47.47
Days Outstanding Inventory (Average Inventory)	89.34	152.57	193.32	150.52	184.54
Average Days Payable Outstanding	20.94	19.13	19.68	18.98	17.17
Cash Conversion Cycle (Average Days)	110.99	177.21	214.83	172.68	214.83
Long Term Solvency
Total Debt/Equity	31.54	41.08	66.78	54.87	48.77
Total Debt / Total Capital	23.98	29.12	40.04	35.43	32.78
LT Debt/Equity	28.71	37.55	58.49	47.86	42.5
Long-Term Debt / Total Capital	21.83	26.62	35.07	30.9	28.57
Total Liabilities / Total Assets	26.74	32.28	42.95	38.98	36.39
EBIT / Interest Expense	0.82	-6.6	-10.98	-2.17	4.96
EBITDA / Interest Expense	9.15	1.07	-4.45	3.43	11.47
(EBITDA - Capex) / Interest Expense	0.86	-10.33	-8.43	2.61	8.93
Total Debt / EBITDA	3.57	33.35	-7.88	7.75	2.33
Net Debt / EBITDA	0.03	17.87	-7.42	5.82	1.66
Total Debt / (EBITDA - Capex)	38.16	-3.47	-4.16	10.19	2.99
Net Debt / (EBITDA - Capex)	0.33	-1.86	-3.92	7.65	2.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.42	-3.51	-5.9	51.64	4.34
Gross Profit, 1 Yr. Growth %	26.13	-11.64	-46.63	89.89	44.13
EBITDA, 1 Yr. Growth %	181.15	-93.06	-422.01	-158.07	394.63
EBITA, 1 Yr. Growth %	-120.31	-924.57	207.66	-76.66	-252.27
EBIT, 1 Yr. Growth %	-118.65	-993.19	205.34	-76.38	-249.33
Earnings From Cont. Operations, 1 Yr. Growth %	-92.34	3.09T	131.56	-62.65	-51.78
Net Income, 1 Yr. Growth %	-92.34	3.09T	131.56	-62.65	-51.78
Normalized Net Income, 1 Yr. Growth %	-97.84	6.43T	194.05	-69.21	-199.4
Diluted EPS Before Extra, 1 Yr. Growth %	-92.72	3.02T	132.93	-64.79	-54.56
Accounts Receivable, 1 Yr. Growth %	49.95	-34.73	24.27	72.56	-9.34
Inventory, 1 Yr. Growth %	47.67	95.42	29.37	-8.95	30.29
Net Property, Plant and Equip., 1 Yr. Growth %	0.1	9.4	4.93	-6.96	-14.9
Total Assets, 1 Yr. Growth %	10.2	0.89	-2.35	2.95	-5.69
Tangible Book Value, 1 Yr. Growth %	15.42	-6.72	-17.76	10.23	-1.62
Common Equity, 1 Yr. Growth %	15.25	-6.74	-17.73	10.1	-1.68
Cash From Operations, 1 Yr. Growth %	-27.47	-261.8	202.76	-107.66	591.61
Capital Expenditures, 1 Yr. Growth %	-35.95	52.39	-52.39	-75.39	168.49
Levered Free Cash Flow, 1 Yr. Growth %	-24.13	181.56	6.4	-122.81	29
Unlevered Free Cash Flow, 1 Yr. Growth %	-27.67	203.74	5.14	-131.67	15.25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.42	10.01	-4.71	19.45	25.79
Gross Profit, 2 Yr. CAGR %	13.33	5.57	-28.73	0.67	61.35
EBITDA, 2 Yr. CAGR %	43.86	-55.83	-4.03	36.74	43.81
EBITA, 2 Yr. CAGR %	-45.62	29.41	333.76	-15.26	-31.12
EBIT, 2 Yr. CAGR %	-48.06	29.05	350.39	-15.08	-31.51
Earnings From Cont. Operations, 2 Yr. CAGR %	-75.42	56.2	758.82	-7.01	-57.56
Net Income, 2 Yr. CAGR %	-75.42	56.2	758.82	-7.01	-57.56
Normalized Net Income, 2 Yr. CAGR %	-82.63	18.84	1.11T	-4.85	-38.5
Diluted EPS Before Extra, 2 Yr. CAGR %	-76.7	50.74	752.82	-9.44	-60
Accounts Receivable, 2 Yr. CAGR %	28.28	-1.07	-9.94	46.44	25.08
Inventory, 2 Yr. CAGR %	10.77	69.88	59	8.53	8.92
Net Property, Plant and Equip., 2 Yr. CAGR %	5.28	4.65	7.14	-1.19	-11.02
Total Assets, 2 Yr. CAGR %	7.2	5.44	-0.74	0.27	-1.47
Tangible Book Value, 2 Yr. CAGR %	6.11	3.76	-12.41	-4.79	4.14
Common Equity, 2 Yr. CAGR %	6	3.67	-12.41	-4.83	4.04
Cash From Operations, 2 Yr. CAGR %	102.14	8.33	121.33	-51.85	-27.23
Capital Expenditures, 2 Yr. CAGR %	36.92	-1.2	-14.83	-65.77	-18.71
Levered Free Cash Flow, 2 Yr. CAGR %	205.51	46.16	66.03	-50.74	-52.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	331.75	48.22	71.05	-42.29	-45.62
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	20.54	10.6	4.43	11.25	14.19
Gross Profit, 3 Yr. CAGR %	18.56	4.31	-13.8	-1.2	11.58
EBITDA, 3 Yr. CAGR %	63.16	-47.63	37.33	-18.83	88.14
EBITA, 3 Yr. CAGR %	-49.35	34.6	56.34	63.75	13.44
EBIT, 3 Yr. CAGR %	-50.69	34.07	55.81	68.58	12.72
Earnings From Cont. Operations, 3 Yr. CAGR %	-67.69	24.39	78.1	202.01	-25.29
Net Income, 3 Yr. CAGR %	-67.69	24.39	78.1	202.01	-25.29
Normalized Net Income, 3 Yr. CAGR %	-75.39	25.38	46.93	256.16	3.61
Diluted EPS Before Extra, 3 Yr. CAGR %	-71.01	19.22	74.27	194.75	-28.04
Accounts Receivable, 3 Yr. CAGR %	42.44	2.41	6.74	11.86	24.81
Inventory, 3 Yr. CAGR %	9.84	33.85	55.13	32.04	15.35
Net Property, Plant and Equip., 3 Yr. CAGR %	2.47	6.64	4.74	2.22	-5.99
Total Assets, 3 Yr. CAGR %	10.75	5.05	2.78	0.47	-1.76
Tangible Book Value, 3 Yr. CAGR %	14.63	1.65	-3.97	-5.43	-3.74
Common Equity, 3 Yr. CAGR %	14.43	1.57	-4.02	-5.47	-3.79
Cash From Operations, 3 Yr. CAGR %	36.71	87.69	52.59	-27.88	17.04
Capital Expenditures, 3 Yr. CAGR %	8.72	41.89	-22.54	-43.69	-31.99
Levered Free Cash Flow, 3 Yr. CAGR %	-12.9	197.31	27.88	-14.34	-38.24
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.36	283.99	28.39	-2.51	-32.25
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.06	12.22	9.72	14.06	12.5
Gross Profit, 5 Yr. CAGR %	9.81	7.93	-3.28	4.37	10.77
EBITDA, 5 Yr. CAGR %	10.18	-22.19	31.96	2.05	39.88
EBITA, 5 Yr. CAGR %	-20.86	59.09	19.58	5.37	12.64
EBIT, 5 Yr. CAGR %	-21.98	56.76	19.45	5.27	12.15
Earnings From Cont. Operations, 5 Yr. CAGR %	-31.22	71.49	19.99	10.73	0.35
Net Income, 5 Yr. CAGR %	-31.22	71.49	19.99	10.73	0.35
Normalized Net Income, 5 Yr. CAGR %	-45	41.57	16.95	6.39	3.71
Diluted EPS Before Extra, 5 Yr. CAGR %	-38.79	56.8	12.13	6.8	-3.27
Accounts Receivable, 5 Yr. CAGR %	22.11	5.52	18.58	18.16	13.73
Inventory, 5 Yr. CAGR %	7.76	24.12	27.36	23.08	34.67
Net Property, Plant and Equip., 5 Yr. CAGR %	23.25	3.28	4.31	3.43	-1.87
Total Assets, 5 Yr. CAGR %	12.48	5.52	6	3.11	1.06
Tangible Book Value, 5 Yr. CAGR %	10.74	5.3	2.93	-0.98	-0.81
Common Equity, 5 Yr. CAGR %	10.56	5.18	2.82	-1.04	-0.87
Cash From Operations, 5 Yr. CAGR %	33.82	5.6	65.77	8.92	13.48
Capital Expenditures, 5 Yr. CAGR %	-8.43	-25.87	-1.39	-19.66	-21.03
Levered Free Cash Flow, 5 Yr. CAGR %	-13.36	-23.08	12.74	42.46	-14.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.94	-23.68	13.74	76.8	-8.94